nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—PDE5A—hypertension	0.487	1	CbGaD
Avanafil—CYP3A4—Guanethidine—hypertension	0.026	0.11	CbGbCtD
Avanafil—CYP3A4—Hydralazine—hypertension	0.0197	0.0837	CbGbCtD
Avanafil—CYP3A4—Guanfacine—hypertension	0.0167	0.0712	CbGbCtD
Avanafil—CYP3A4—Isradipine—hypertension	0.0149	0.0634	CbGbCtD
Avanafil—CYP3A4—Nisoldipine—hypertension	0.0131	0.0558	CbGbCtD
Avanafil—CYP3A4—Indapamide—hypertension	0.0131	0.0558	CbGbCtD
Avanafil—CYP3A4—Diltiazem—hypertension	0.0127	0.0539	CbGbCtD
Avanafil—CYP3A4—Eplerenone—hypertension	0.0127	0.0539	CbGbCtD
Avanafil—CYP3A4—Enalapril—hypertension	0.0113	0.0481	CbGbCtD
Avanafil—CYP3A4—Irbesartan—hypertension	0.0103	0.044	CbGbCtD
Avanafil—CYP3A4—Amlodipine—hypertension	0.0101	0.0431	CbGbCtD
Avanafil—CYP3A4—Felodipine—hypertension	0.00978	0.0416	CbGbCtD
Avanafil—CYP3A4—Nifedipine—hypertension	0.00946	0.0402	CbGbCtD
Avanafil—CYP3A4—Carvedilol—hypertension	0.00931	0.0396	CbGbCtD
Avanafil—CYP3A4—Nicardipine—hypertension	0.00931	0.0396	CbGbCtD
Avanafil—PDE5A—pulmonary artery—hypertension	0.00909	0.345	CbGeAlD
Avanafil—CYP3A4—Propranolol—hypertension	0.00857	0.0364	CbGbCtD
Avanafil—CYP3A4—Clonidine—hypertension	0.00817	0.0348	CbGbCtD
Avanafil—CYP3A4—Atorvastatin—hypertension	0.00728	0.031	CbGbCtD
Avanafil—CYP3A4—Losartan—hypertension	0.00666	0.0283	CbGbCtD
Avanafil—CYP3A4—Verapamil—hypertension	0.00588	0.025	CbGbCtD
Avanafil—PDE5A—artery—hypertension	0.00337	0.128	CbGeAlD
Avanafil—PDE5A—endothelium—hypertension	0.00285	0.108	CbGeAlD
Avanafil—PDE5A—blood vessel—hypertension	0.00262	0.0996	CbGeAlD
Avanafil—CYP3A4—urine—hypertension	0.00151	0.0573	CbGeAlD
Avanafil—PDE5A—heart—hypertension	0.00124	0.0471	CbGeAlD
Avanafil—PDE5A—smooth muscle tissue—hypertension	0.00123	0.0467	CbGeAlD
Avanafil—PDE5A—cardiovascular system—hypertension	0.00117	0.0444	CbGeAlD
Avanafil—PDE5A—adrenal gland—hypertension	0.000926	0.0351	CbGeAlD
Avanafil—PDE5A—endocrine gland—hypertension	0.000803	0.0305	CbGeAlD
Avanafil—PDE5A—central nervous system—hypertension	0.000724	0.0275	CbGeAlD
Avanafil—CYP3A4—kidney—hypertension	0.000357	0.0135	CbGeAlD
Avanafil—CYP3A4—endocrine gland—hypertension	0.00025	0.0095	CbGeAlD
Avanafil—CYP3A4—central nervous system—hypertension	0.000226	0.00856	CbGeAlD
Avanafil—PDE5A—Hemostasis—TIMP1—hypertension	0.000111	0.00179	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B1—hypertension	0.00011	0.00178	CbGpPWpGaD
Avanafil—CYP3A4—Estrogen metabolism—GSTM1—hypertension	0.00011	0.00177	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4A11—hypertension	0.000107	0.00173	CbGpPWpGaD
Avanafil—CYP3A4—Oxidation by Cytochrome P450—CYP4A11—hypertension	0.000106	0.00171	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—NOS1—hypertension	0.000104	0.00168	CbGpPWpGaD
Avanafil—CYP3A4—Estrogen metabolism—CYP1A1—hypertension	0.000104	0.00168	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—CALM2—hypertension	0.000104	0.00168	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2J2—hypertension	0.000103	0.00167	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—PTGIS—hypertension	0.000103	0.00167	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP3A5—hypertension	0.000103	0.00167	CbGpPWpGaD
Avanafil—CYP3A4—Oxidation by Cytochrome P450—CYP3A5—hypertension	0.000102	0.00164	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PTPN1—hypertension	0.000101	0.00164	CbGpPWpGaD
Avanafil—CYP3A4—Tryptophan metabolism—CYP2C18—hypertension	0.0001	0.00162	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—ITGAV—hypertension	9.75e-05	0.00157	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—KNG1—hypertension	9.72e-05	0.00157	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11B2—hypertension	9.65e-05	0.00156	CbGpPWpGaD
Avanafil—CYP3A4—Xenobiotics—CYP1A1—hypertension	9.55e-05	0.00154	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—HDAC1—hypertension	9.52e-05	0.00154	CbGpPWpGaD
Avanafil—CYP3A4—Oxidation by Cytochrome P450—CYP11B2—hypertension	9.52e-05	0.00154	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PLG—hypertension	9.42e-05	0.00152	CbGpPWpGaD
Avanafil—CYP3A4—Tamoxifen metabolism—CYP1A1—hypertension	9.18e-05	0.00148	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—hypertension	9.11e-05	0.00147	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PRKCE—hypertension	9.05e-05	0.00146	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—SOD1—hypertension	9.03e-05	0.00146	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—VAV3—hypertension	8.94e-05	0.00144	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PDGFA—hypertension	8.94e-05	0.00144	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—GNB3—hypertension	8.73e-05	0.00141	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP4A11—hypertension	8.68e-05	0.0014	CbGpPWpGaD
Avanafil—CYP3A4—Tryptophan metabolism—ALDH2—hypertension	8.54e-05	0.00138	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—GNAS—hypertension	8.5e-05	0.00137	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP3A5—hypertension	8.36e-05	0.00135	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—PTGIS—hypertension	8.36e-05	0.00135	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—APOB—hypertension	8.32e-05	0.00134	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PTK2—hypertension	8.29e-05	0.00134	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—hypertension	8.12e-05	0.00131	CbGpPWpGaD
Avanafil—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—hypertension	8.01e-05	0.00129	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B2—hypertension	7.82e-05	0.00126	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PRKCG—hypertension	7.73e-05	0.00125	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—ITGB3—hypertension	7.68e-05	0.00124	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PRKCA—hypertension	7.68e-05	0.00124	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—YWHAZ—hypertension	7.61e-05	0.00123	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—CD36—hypertension	7.55e-05	0.00122	CbGpPWpGaD
Avanafil—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—hypertension	7.46e-05	0.0012	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—hypertension	7.38e-05	0.00119	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PRKCD—hypertension	7.32e-05	0.00118	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—GSTA5—hypertension	7.02e-05	0.00113	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PDGFB—hypertension	6.97e-05	0.00112	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—GSTA5—hypertension	6.92e-05	0.00112	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—MMP1—hypertension	6.88e-05	0.00111	CbGpPWpGaD
Avanafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—hypertension	6.77e-05	0.00109	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—hypertension	6.69e-05	0.00108	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—CALM1—hypertension	6.69e-05	0.00108	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—GSTT2—hypertension	6.66e-05	0.00107	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—CAV1—hypertension	6.6e-05	0.00107	CbGpPWpGaD
Avanafil—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—hypertension	6.6e-05	0.00107	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—APOA1—hypertension	6.59e-05	0.00106	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—hypertension	6.58e-05	0.00106	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—GSTT2—hypertension	6.56e-05	0.00106	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—CYP4F12—hypertension	6.35e-05	0.00103	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—F2—hypertension	6.28e-05	0.00101	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—FN1—hypertension	6.28e-05	0.00101	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PRKCB—hypertension	6.28e-05	0.00101	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—CYP4F12—hypertension	6.26e-05	0.00101	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—hypertension	6.22e-05	0.001	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—NOS2—hypertension	6.21e-05	0.001	CbGpPWpGaD
Avanafil—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—hypertension	6.13e-05	0.000991	CbGpPWpGaD
Avanafil—CYP3A4—Tryptophan metabolism—CYP19A1—hypertension	6.08e-05	0.000983	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—AHCY—hypertension	5.86e-05	0.000946	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—CYP11B1—hypertension	5.86e-05	0.000946	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—CYP11B1—hypertension	5.78e-05	0.000933	CbGpPWpGaD
Avanafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—hypertension	5.71e-05	0.000923	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—GSTM5—hypertension	5.66e-05	0.000914	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—hypertension	5.6e-05	0.000904	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—EPHX2—hypertension	5.58e-05	0.000901	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—EPHX1—hypertension	5.58e-05	0.000901	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—GSTM5—hypertension	5.58e-05	0.000901	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—IGF1—hypertension	5.51e-05	0.000889	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—AKT2—hypertension	5.5e-05	0.000888	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—CYP2J2—hypertension	5.48e-05	0.000885	CbGpPWpGaD
Avanafil—CYP3A4—Tryptophan metabolism—CAT—hypertension	5.48e-05	0.000885	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—hypertension	5.42e-05	0.000875	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—CYP2J2—hypertension	5.41e-05	0.000873	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—SERPINE1—hypertension	5.23e-05	0.000844	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—ALB—hypertension	5.22e-05	0.000843	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—RHOA—hypertension	5.04e-05	0.000814	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—hypertension	5.04e-05	0.000814	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PIK3R1—hypertension	4.99e-05	0.000806	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—NOS3—hypertension	4.99e-05	0.000806	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—hypertension	4.99e-05	0.000806	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—hypertension	4.92e-05	0.000794	CbGpPWpGaD
Avanafil—CYP3A4—Tryptophan metabolism—CYP1A1—hypertension	4.9e-05	0.000792	CbGpPWpGaD
Avanafil—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—hypertension	4.85e-05	0.000784	CbGpPWpGaD
Avanafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—hypertension	4.72e-05	0.000763	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—CYP4A11—hypertension	4.61e-05	0.000745	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—PTGIS—hypertension	4.44e-05	0.000717	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—CYP3A5—hypertension	4.44e-05	0.000717	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—CYP3A5—hypertension	4.38e-05	0.000707	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—CYP11B2—hypertension	4.15e-05	0.000671	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—CYP11B2—hypertension	4.1e-05	0.000662	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—hypertension	3.99e-05	0.000644	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—hypertension	3.97e-05	0.00064	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—TBXAS1—hypertension	3.92e-05	0.000634	CbGpPWpGaD
Avanafil—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—hypertension	3.91e-05	0.000632	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—EP300—hypertension	3.8e-05	0.000613	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—SRC—hypertension	3.69e-05	0.000596	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—VEGFA—hypertension	3.6e-05	0.000581	CbGpPWpGaD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Ramipril—hypertension	3.5e-05	0.000185	CcSEcCtD
Avanafil—Asthenia—Valsartan—hypertension	3.5e-05	0.000185	CcSEcCtD
Avanafil—Hypertension—Timolol—hypertension	3.5e-05	0.000185	CcSEcCtD
Avanafil—CYP3A4—Biological oxidations—CYP2C18—hypertension	3.5e-05	0.000565	CbGpPWpGaD
Avanafil—Constipation—Furosemide—hypertension	3.5e-05	0.000185	CcSEcCtD
Avanafil—Gastrointestinal disorder—Betaxolol—hypertension	3.49e-05	0.000185	CcSEcCtD
Avanafil—Fatigue—Betaxolol—hypertension	3.49e-05	0.000184	CcSEcCtD
Avanafil—Asthenia—Olmesartan—hypertension	3.48e-05	0.000184	CcSEcCtD
Avanafil—Dizziness—Nifedipine—hypertension	3.48e-05	0.000184	CcSEcCtD
Avanafil—Rash—Indapamide—hypertension	3.48e-05	0.000184	CcSEcCtD
Avanafil—Rash—Diltiazem—hypertension	3.48e-05	0.000184	CcSEcCtD
Avanafil—Dermatitis—Indapamide—hypertension	3.47e-05	0.000183	CcSEcCtD
Avanafil—Dermatitis—Diltiazem—hypertension	3.47e-05	0.000183	CcSEcCtD
Avanafil—Dyspepsia—Losartan—hypertension	3.47e-05	0.000183	CcSEcCtD
Avanafil—Vomiting—Carvedilol—hypertension	3.47e-05	0.000183	CcSEcCtD
Avanafil—Dizziness—Verapamil—hypertension	3.46e-05	0.000183	CcSEcCtD
Avanafil—Constipation—Betaxolol—hypertension	3.46e-05	0.000183	CcSEcCtD
Avanafil—Headache—Diltiazem—hypertension	3.45e-05	0.000182	CcSEcCtD
Avanafil—Headache—Indapamide—hypertension	3.45e-05	0.000182	CcSEcCtD
Avanafil—Pruritus—Valsartan—hypertension	3.45e-05	0.000182	CcSEcCtD
Avanafil—Dry mouth—Ramipril—hypertension	3.45e-05	0.000182	CcSEcCtD
Avanafil—Arthralgia—Timolol—hypertension	3.45e-05	0.000182	CcSEcCtD
Avanafil—Chest pain—Timolol—hypertension	3.45e-05	0.000182	CcSEcCtD
Avanafil—Myalgia—Timolol—hypertension	3.45e-05	0.000182	CcSEcCtD
Avanafil—CYP3A4—Metapathway biotransformation—CYP2C18—hypertension	3.45e-05	0.000557	CbGpPWpGaD
Avanafil—Rash—Carvedilol—hypertension	3.44e-05	0.000182	CcSEcCtD
Avanafil—Dermatitis—Carvedilol—hypertension	3.44e-05	0.000182	CcSEcCtD
Avanafil—Pruritus—Olmesartan—hypertension	3.43e-05	0.000181	CcSEcCtD
Avanafil—Vomiting—Doxazosin—hypertension	3.43e-05	0.000181	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	3.43e-05	0.000181	CcSEcCtD
Avanafil—Body temperature increased—Captopril—hypertension	3.42e-05	0.000181	CcSEcCtD
Avanafil—Headache—Carvedilol—hypertension	3.42e-05	0.000181	CcSEcCtD
Avanafil—Rash—Doxazosin—hypertension	3.4e-05	0.00018	CcSEcCtD
Avanafil—Fatigue—Losartan—hypertension	3.4e-05	0.00018	CcSEcCtD
Avanafil—Dermatitis—Doxazosin—hypertension	3.4e-05	0.00018	CcSEcCtD
Avanafil—Vomiting—Fosinopril—hypertension	3.39e-05	0.000179	CcSEcCtD
Avanafil—Nausea—Propranolol—hypertension	3.38e-05	0.000179	CcSEcCtD
Avanafil—Headache—Doxazosin—hypertension	3.38e-05	0.000179	CcSEcCtD
Avanafil—Vertigo—Lisinopril—hypertension	3.38e-05	0.000178	CcSEcCtD
Avanafil—Dry mouth—Timolol—hypertension	3.37e-05	0.000178	CcSEcCtD
Avanafil—Constipation—Losartan—hypertension	3.37e-05	0.000178	CcSEcCtD
Avanafil—Vomiting—Eplerenone—hypertension	3.37e-05	0.000178	CcSEcCtD
Avanafil—Rash—Fosinopril—hypertension	3.36e-05	0.000178	CcSEcCtD
Avanafil—Dermatitis—Fosinopril—hypertension	3.36e-05	0.000178	CcSEcCtD
Avanafil—Vomiting—Nifedipine—hypertension	3.35e-05	0.000177	CcSEcCtD
Avanafil—Rash—Eplerenone—hypertension	3.34e-05	0.000177	CcSEcCtD
Avanafil—Headache—Fosinopril—hypertension	3.34e-05	0.000177	CcSEcCtD
Avanafil—Dermatitis—Eplerenone—hypertension	3.34e-05	0.000176	CcSEcCtD
Avanafil—Diarrhoea—Valsartan—hypertension	3.34e-05	0.000176	CcSEcCtD
Avanafil—Asthenia—Clonidine—hypertension	3.34e-05	0.000176	CcSEcCtD
Avanafil—Vomiting—Verapamil—hypertension	3.33e-05	0.000176	CcSEcCtD
Avanafil—Body temperature increased—Perindopril—hypertension	3.32e-05	0.000176	CcSEcCtD
Avanafil—Palpitations—Lisinopril—hypertension	3.32e-05	0.000176	CcSEcCtD
Avanafil—Diarrhoea—Olmesartan—hypertension	3.32e-05	0.000175	CcSEcCtD
Avanafil—Headache—Eplerenone—hypertension	3.32e-05	0.000175	CcSEcCtD
Avanafil—Rash—Nifedipine—hypertension	3.32e-05	0.000175	CcSEcCtD
Avanafil—Nervous system disorder—Ramipril—hypertension	3.32e-05	0.000175	CcSEcCtD
Avanafil—Dermatitis—Nifedipine—hypertension	3.31e-05	0.000175	CcSEcCtD
Avanafil—Body temperature increased—Irbesartan—hypertension	3.31e-05	0.000175	CcSEcCtD
Avanafil—Rash—Verapamil—hypertension	3.3e-05	0.000175	CcSEcCtD
Avanafil—Tachycardia—Ramipril—hypertension	3.3e-05	0.000174	CcSEcCtD
Avanafil—PDE5A—Hemostasis—TGFB1—hypertension	3.3e-05	0.000533	CbGpPWpGaD
Avanafil—Dermatitis—Verapamil—hypertension	3.3e-05	0.000174	CcSEcCtD
Avanafil—Headache—Nifedipine—hypertension	3.3e-05	0.000174	CcSEcCtD
Avanafil—Pruritus—Clonidine—hypertension	3.29e-05	0.000174	CcSEcCtD
Avanafil—Body temperature increased—Hydrochlorothiazide—hypertension	3.29e-05	0.000174	CcSEcCtD
Avanafil—Skin disorder—Ramipril—hypertension	3.29e-05	0.000174	CcSEcCtD
Avanafil—Infection—Timolol—hypertension	3.28e-05	0.000174	CcSEcCtD
Avanafil—Headache—Verapamil—hypertension	3.28e-05	0.000173	CcSEcCtD
Avanafil—Cough—Lisinopril—hypertension	3.28e-05	0.000173	CcSEcCtD
Avanafil—Nausea—Indapamide—hypertension	3.27e-05	0.000173	CcSEcCtD
Avanafil—Nausea—Diltiazem—hypertension	3.27e-05	0.000173	CcSEcCtD
Avanafil—Asthenia—Trandolapril—hypertension	3.25e-05	0.000172	CcSEcCtD
Avanafil—Nervous system disorder—Timolol—hypertension	3.24e-05	0.000171	CcSEcCtD
Avanafil—Nausea—Carvedilol—hypertension	3.24e-05	0.000171	CcSEcCtD
Avanafil—Asthenia—Enalapril—hypertension	3.24e-05	0.000171	CcSEcCtD
Avanafil—Body temperature increased—Furosemide—hypertension	3.23e-05	0.000171	CcSEcCtD
Avanafil—Dizziness—Valsartan—hypertension	3.23e-05	0.00017	CcSEcCtD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—hypertension	3.21e-05	0.000519	CbGpPWpGaD
Avanafil—Skin disorder—Timolol—hypertension	3.21e-05	0.00017	CcSEcCtD
Avanafil—Dizziness—Olmesartan—hypertension	3.21e-05	0.00017	CcSEcCtD
Avanafil—Pruritus—Trandolapril—hypertension	3.21e-05	0.00017	CcSEcCtD
Avanafil—Nausea—Doxazosin—hypertension	3.21e-05	0.000169	CcSEcCtD
Avanafil—Chest pain—Lisinopril—hypertension	3.2e-05	0.000169	CcSEcCtD
Avanafil—Myalgia—Lisinopril—hypertension	3.2e-05	0.000169	CcSEcCtD
Avanafil—Arthralgia—Lisinopril—hypertension	3.2e-05	0.000169	CcSEcCtD
Avanafil—Body temperature increased—Betaxolol—hypertension	3.2e-05	0.000169	CcSEcCtD
Avanafil—Asthenia—Telmisartan—hypertension	3.2e-05	0.000169	CcSEcCtD
Avanafil—Pruritus—Enalapril—hypertension	3.2e-05	0.000169	CcSEcCtD
Avanafil—Diarrhoea—Clonidine—hypertension	3.18e-05	0.000168	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	3.18e-05	0.000168	CcSEcCtD
Avanafil—Nausea—Fosinopril—hypertension	3.17e-05	0.000167	CcSEcCtD
Avanafil—Hypotension—Ramipril—hypertension	3.16e-05	0.000167	CcSEcCtD
Avanafil—Pruritus—Telmisartan—hypertension	3.15e-05	0.000167	CcSEcCtD
Avanafil—Nausea—Eplerenone—hypertension	3.15e-05	0.000166	CcSEcCtD
Avanafil—Dry mouth—Lisinopril—hypertension	3.13e-05	0.000165	CcSEcCtD
Avanafil—Nausea—Nifedipine—hypertension	3.13e-05	0.000165	CcSEcCtD
Avanafil—Body temperature increased—Losartan—hypertension	3.12e-05	0.000165	CcSEcCtD
Avanafil—Nausea—Verapamil—hypertension	3.11e-05	0.000164	CcSEcCtD
Avanafil—Asthenia—Captopril—hypertension	3.11e-05	0.000164	CcSEcCtD
Avanafil—Diarrhoea—Trandolapril—hypertension	3.1e-05	0.000164	CcSEcCtD
Avanafil—Vomiting—Valsartan—hypertension	3.1e-05	0.000164	CcSEcCtD
Avanafil—Diarrhoea—Enalapril—hypertension	3.09e-05	0.000163	CcSEcCtD
Avanafil—Hypotension—Timolol—hypertension	3.09e-05	0.000163	CcSEcCtD
Avanafil—Vomiting—Olmesartan—hypertension	3.09e-05	0.000163	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Ramipril—hypertension	3.08e-05	0.000163	CcSEcCtD
Avanafil—Rash—Valsartan—hypertension	3.08e-05	0.000163	CcSEcCtD
Avanafil—Dizziness—Clonidine—hypertension	3.07e-05	0.000162	CcSEcCtD
Avanafil—Dermatitis—Valsartan—hypertension	3.07e-05	0.000162	CcSEcCtD
Avanafil—Pruritus—Captopril—hypertension	3.06e-05	0.000162	CcSEcCtD
Avanafil—Rash—Olmesartan—hypertension	3.06e-05	0.000162	CcSEcCtD
Avanafil—Insomnia—Ramipril—hypertension	3.06e-05	0.000162	CcSEcCtD
Avanafil—CYP3A4—Metapathway biotransformation—GPX3—hypertension	3.06e-05	0.000494	CbGpPWpGaD
Avanafil—Dermatitis—Olmesartan—hypertension	3.06e-05	0.000162	CcSEcCtD
Avanafil—Headache—Valsartan—hypertension	3.06e-05	0.000161	CcSEcCtD
Avanafil—Diarrhoea—Telmisartan—hypertension	3.05e-05	0.000161	CcSEcCtD
Avanafil—Infection—Lisinopril—hypertension	3.05e-05	0.000161	CcSEcCtD
Avanafil—Headache—Olmesartan—hypertension	3.04e-05	0.000161	CcSEcCtD
Avanafil—Asthenia—Perindopril—hypertension	3.02e-05	0.000159	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Timolol—hypertension	3.01e-05	0.000159	CcSEcCtD
Avanafil—Asthenia—Irbesartan—hypertension	3.01e-05	0.000159	CcSEcCtD
Avanafil—Somnolence—Ramipril—hypertension	3.01e-05	0.000159	CcSEcCtD
Avanafil—Dizziness—Trandolapril—hypertension	3e-05	0.000158	CcSEcCtD
Avanafil—Tachycardia—Lisinopril—hypertension	2.99e-05	0.000158	CcSEcCtD
Avanafil—Insomnia—Timolol—hypertension	2.99e-05	0.000158	CcSEcCtD
Avanafil—Dizziness—Enalapril—hypertension	2.99e-05	0.000158	CcSEcCtD
Avanafil—Asthenia—Hydrochlorothiazide—hypertension	2.98e-05	0.000158	CcSEcCtD
Avanafil—Skin disorder—Lisinopril—hypertension	2.98e-05	0.000157	CcSEcCtD
Avanafil—Dyspepsia—Ramipril—hypertension	2.98e-05	0.000157	CcSEcCtD
Avanafil—Pruritus—Perindopril—hypertension	2.98e-05	0.000157	CcSEcCtD
Avanafil—CYP3A4—Biological oxidations—ALDH2—hypertension	2.97e-05	0.00048	CbGpPWpGaD
Avanafil—Pruritus—Irbesartan—hypertension	2.97e-05	0.000157	CcSEcCtD
Avanafil—Diarrhoea—Captopril—hypertension	2.96e-05	0.000157	CcSEcCtD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypertension	2.96e-05	0.000477	CbGpPWpGaD
Avanafil—Vomiting—Clonidine—hypertension	2.96e-05	0.000156	CcSEcCtD
Avanafil—Dizziness—Telmisartan—hypertension	2.95e-05	0.000156	CcSEcCtD
Avanafil—Pruritus—Hydrochlorothiazide—hypertension	2.94e-05	0.000155	CcSEcCtD
Avanafil—Somnolence—Timolol—hypertension	2.94e-05	0.000155	CcSEcCtD
Avanafil—Asthenia—Furosemide—hypertension	2.93e-05	0.000155	CcSEcCtD
Avanafil—Rash—Clonidine—hypertension	2.93e-05	0.000155	CcSEcCtD
Avanafil—Dermatitis—Clonidine—hypertension	2.93e-05	0.000155	CcSEcCtD
Avanafil—Gastrointestinal disorder—Ramipril—hypertension	2.92e-05	0.000154	CcSEcCtD
Avanafil—Fatigue—Ramipril—hypertension	2.92e-05	0.000154	CcSEcCtD
Avanafil—Headache—Clonidine—hypertension	2.91e-05	0.000154	CcSEcCtD
Avanafil—Dyspepsia—Timolol—hypertension	2.91e-05	0.000154	CcSEcCtD
Avanafil—Asthenia—Betaxolol—hypertension	2.9e-05	0.000153	CcSEcCtD
Avanafil—Nausea—Valsartan—hypertension	2.9e-05	0.000153	CcSEcCtD
Avanafil—Pruritus—Furosemide—hypertension	2.89e-05	0.000153	CcSEcCtD
Avanafil—Constipation—Ramipril—hypertension	2.89e-05	0.000153	CcSEcCtD
Avanafil—Nausea—Olmesartan—hypertension	2.88e-05	0.000152	CcSEcCtD
Avanafil—Vomiting—Trandolapril—hypertension	2.88e-05	0.000152	CcSEcCtD
Avanafil—CYP3A4—Biological oxidations—CYP11A1—hypertension	2.88e-05	0.000465	CbGpPWpGaD
Avanafil—Diarrhoea—Perindopril—hypertension	2.88e-05	0.000152	CcSEcCtD
Avanafil—Vomiting—Enalapril—hypertension	2.87e-05	0.000152	CcSEcCtD
Avanafil—Diarrhoea—Irbesartan—hypertension	2.87e-05	0.000152	CcSEcCtD
Avanafil—Hypotension—Lisinopril—hypertension	2.87e-05	0.000151	CcSEcCtD
Avanafil—Dizziness—Captopril—hypertension	2.86e-05	0.000151	CcSEcCtD
Avanafil—Pruritus—Betaxolol—hypertension	2.86e-05	0.000151	CcSEcCtD
Avanafil—Rash—Trandolapril—hypertension	2.86e-05	0.000151	CcSEcCtD
Avanafil—Dermatitis—Trandolapril—hypertension	2.86e-05	0.000151	CcSEcCtD
Avanafil—Gastrointestinal disorder—Timolol—hypertension	2.85e-05	0.000151	CcSEcCtD
Avanafil—Fatigue—Timolol—hypertension	2.85e-05	0.000151	CcSEcCtD
Avanafil—Rash—Enalapril—hypertension	2.85e-05	0.00015	CcSEcCtD
Avanafil—Dermatitis—Enalapril—hypertension	2.84e-05	0.00015	CcSEcCtD
Avanafil—Diarrhoea—Hydrochlorothiazide—hypertension	2.84e-05	0.00015	CcSEcCtD
Avanafil—Headache—Trandolapril—hypertension	2.84e-05	0.00015	CcSEcCtD
Avanafil—CYP3A4—Metapathway biotransformation—CYP11A1—hypertension	2.84e-05	0.000459	CbGpPWpGaD
Avanafil—Vomiting—Telmisartan—hypertension	2.83e-05	0.00015	CcSEcCtD
Avanafil—Asthenia—Losartan—hypertension	2.83e-05	0.00015	CcSEcCtD
Avanafil—Headache—Enalapril—hypertension	2.83e-05	0.000149	CcSEcCtD
Avanafil—CYP3A4—Biological oxidations—GSTT1—hypertension	2.83e-05	0.000457	CbGpPWpGaD
Avanafil—Rash—Telmisartan—hypertension	2.81e-05	0.000148	CcSEcCtD
Avanafil—Dermatitis—Telmisartan—hypertension	2.81e-05	0.000148	CcSEcCtD
Avanafil—Diarrhoea—Furosemide—hypertension	2.8e-05	0.000148	CcSEcCtD
Avanafil—CYP3A4—Biological oxidations—GCLC—hypertension	2.8e-05	0.000451	CbGpPWpGaD
Avanafil—Musculoskeletal discomfort—Lisinopril—hypertension	2.79e-05	0.000148	CcSEcCtD
Avanafil—Pruritus—Losartan—hypertension	2.79e-05	0.000147	CcSEcCtD
Avanafil—Headache—Telmisartan—hypertension	2.79e-05	0.000147	CcSEcCtD
Avanafil—Dizziness—Perindopril—hypertension	2.78e-05	0.000147	CcSEcCtD
Avanafil—Insomnia—Lisinopril—hypertension	2.77e-05	0.000147	CcSEcCtD
Avanafil—Dizziness—Irbesartan—hypertension	2.77e-05	0.000146	CcSEcCtD
Avanafil—Diarrhoea—Betaxolol—hypertension	2.77e-05	0.000146	CcSEcCtD
Avanafil—Nausea—Clonidine—hypertension	2.76e-05	0.000146	CcSEcCtD
Avanafil—Vomiting—Captopril—hypertension	2.75e-05	0.000146	CcSEcCtD
Avanafil—Dizziness—Hydrochlorothiazide—hypertension	2.75e-05	0.000145	CcSEcCtD
Avanafil—Rash—Captopril—hypertension	2.73e-05	0.000144	CcSEcCtD
Avanafil—Dermatitis—Captopril—hypertension	2.73e-05	0.000144	CcSEcCtD
Avanafil—Somnolence—Lisinopril—hypertension	2.73e-05	0.000144	CcSEcCtD
Avanafil—PDE5A—Hemostasis—TP53—hypertension	2.72e-05	0.000439	CbGpPWpGaD
Avanafil—Headache—Captopril—hypertension	2.71e-05	0.000143	CcSEcCtD
Avanafil—Dizziness—Furosemide—hypertension	2.7e-05	0.000143	CcSEcCtD
Avanafil—Dyspepsia—Lisinopril—hypertension	2.7e-05	0.000143	CcSEcCtD
Avanafil—Diarrhoea—Losartan—hypertension	2.7e-05	0.000143	CcSEcCtD
Avanafil—Nausea—Trandolapril—hypertension	2.69e-05	0.000142	CcSEcCtD
Avanafil—Nausea—Enalapril—hypertension	2.68e-05	0.000142	CcSEcCtD
Avanafil—CYP3A4—Biological oxidations—CYP17A1—hypertension	2.68e-05	0.000432	CbGpPWpGaD
Avanafil—Dizziness—Betaxolol—hypertension	2.68e-05	0.000141	CcSEcCtD
Avanafil—Vomiting—Perindopril—hypertension	2.67e-05	0.000141	CcSEcCtD
Avanafil—Body temperature increased—Ramipril—hypertension	2.67e-05	0.000141	CcSEcCtD
Avanafil—Vomiting—Irbesartan—hypertension	2.66e-05	0.000141	CcSEcCtD
Avanafil—Rash—Perindopril—hypertension	2.65e-05	0.00014	CcSEcCtD
Avanafil—CYP3A4—Biological oxidations—PTGS1—hypertension	2.65e-05	0.000428	CbGpPWpGaD
Avanafil—Dermatitis—Perindopril—hypertension	2.65e-05	0.00014	CcSEcCtD
Avanafil—Gastrointestinal disorder—Lisinopril—hypertension	2.65e-05	0.00014	CcSEcCtD
Avanafil—Nausea—Telmisartan—hypertension	2.65e-05	0.00014	CcSEcCtD
Avanafil—Fatigue—Lisinopril—hypertension	2.64e-05	0.00014	CcSEcCtD
Avanafil—Vomiting—Hydrochlorothiazide—hypertension	2.64e-05	0.00014	CcSEcCtD
Avanafil—Rash—Irbesartan—hypertension	2.64e-05	0.00014	CcSEcCtD
Avanafil—Dermatitis—Irbesartan—hypertension	2.64e-05	0.00014	CcSEcCtD
Avanafil—CYP3A4—Metapathway biotransformation—CYP17A1—hypertension	2.64e-05	0.000426	CbGpPWpGaD
Avanafil—Headache—Perindopril—hypertension	2.63e-05	0.000139	CcSEcCtD
Avanafil—Headache—Irbesartan—hypertension	2.63e-05	0.000139	CcSEcCtD
Avanafil—Constipation—Lisinopril—hypertension	2.62e-05	0.000139	CcSEcCtD
Avanafil—Rash—Hydrochlorothiazide—hypertension	2.62e-05	0.000139	CcSEcCtD
Avanafil—Dermatitis—Hydrochlorothiazide—hypertension	2.62e-05	0.000138	CcSEcCtD
Avanafil—Body temperature increased—Timolol—hypertension	2.61e-05	0.000138	CcSEcCtD
Avanafil—Dizziness—Losartan—hypertension	2.61e-05	0.000138	CcSEcCtD
Avanafil—Headache—Hydrochlorothiazide—hypertension	2.6e-05	0.000138	CcSEcCtD
Avanafil—Vomiting—Furosemide—hypertension	2.6e-05	0.000137	CcSEcCtD
Avanafil—Rash—Furosemide—hypertension	2.58e-05	0.000136	CcSEcCtD
Avanafil—Dermatitis—Furosemide—hypertension	2.58e-05	0.000136	CcSEcCtD
Avanafil—Vomiting—Betaxolol—hypertension	2.57e-05	0.000136	CcSEcCtD
Avanafil—Nausea—Captopril—hypertension	2.57e-05	0.000136	CcSEcCtD
Avanafil—Headache—Furosemide—hypertension	2.56e-05	0.000135	CcSEcCtD
Avanafil—Rash—Betaxolol—hypertension	2.55e-05	0.000135	CcSEcCtD
Avanafil—Dermatitis—Betaxolol—hypertension	2.55e-05	0.000135	CcSEcCtD
Avanafil—Headache—Betaxolol—hypertension	2.54e-05	0.000134	CcSEcCtD
Avanafil—Vomiting—Losartan—hypertension	2.51e-05	0.000133	CcSEcCtD
Avanafil—Nausea—Perindopril—hypertension	2.5e-05	0.000132	CcSEcCtD
Avanafil—Nausea—Irbesartan—hypertension	2.49e-05	0.000132	CcSEcCtD
Avanafil—Rash—Losartan—hypertension	2.49e-05	0.000131	CcSEcCtD
Avanafil—Dermatitis—Losartan—hypertension	2.48e-05	0.000131	CcSEcCtD
Avanafil—Headache—Losartan—hypertension	2.47e-05	0.000131	CcSEcCtD
Avanafil—Nausea—Hydrochlorothiazide—hypertension	2.47e-05	0.00013	CcSEcCtD
Avanafil—Nausea—Furosemide—hypertension	2.43e-05	0.000128	CcSEcCtD
Avanafil—Asthenia—Ramipril—hypertension	2.43e-05	0.000128	CcSEcCtD
Avanafil—Body temperature increased—Lisinopril—hypertension	2.42e-05	0.000128	CcSEcCtD
Avanafil—Nausea—Betaxolol—hypertension	2.4e-05	0.000127	CcSEcCtD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypertension	2.4e-05	0.000387	CbGpPWpGaD
Avanafil—Pruritus—Ramipril—hypertension	2.39e-05	0.000126	CcSEcCtD
Avanafil—Asthenia—Timolol—hypertension	2.37e-05	0.000125	CcSEcCtD
Avanafil—Nausea—Losartan—hypertension	2.34e-05	0.000124	CcSEcCtD
Avanafil—Pruritus—Timolol—hypertension	2.34e-05	0.000124	CcSEcCtD
Avanafil—Diarrhoea—Ramipril—hypertension	2.31e-05	0.000122	CcSEcCtD
Avanafil—PDE5A—Hemostasis—AKT1—hypertension	2.29e-05	0.000371	CbGpPWpGaD
Avanafil—Diarrhoea—Timolol—hypertension	2.26e-05	0.00012	CcSEcCtD
Avanafil—Dizziness—Ramipril—hypertension	2.24e-05	0.000118	CcSEcCtD
Avanafil—Asthenia—Lisinopril—hypertension	2.2e-05	0.000116	CcSEcCtD
Avanafil—Dizziness—Timolol—hypertension	2.19e-05	0.000116	CcSEcCtD
Avanafil—Pruritus—Lisinopril—hypertension	2.17e-05	0.000115	CcSEcCtD
Avanafil—Vomiting—Ramipril—hypertension	2.15e-05	0.000114	CcSEcCtD
Avanafil—Rash—Ramipril—hypertension	2.13e-05	0.000113	CcSEcCtD
Avanafil—Dermatitis—Ramipril—hypertension	2.13e-05	0.000113	CcSEcCtD
Avanafil—Headache—Ramipril—hypertension	2.12e-05	0.000112	CcSEcCtD
Avanafil—CYP3A4—Biological oxidations—CYP19A1—hypertension	2.12e-05	0.000342	CbGpPWpGaD
Avanafil—Vomiting—Timolol—hypertension	2.1e-05	0.000111	CcSEcCtD
Avanafil—Diarrhoea—Lisinopril—hypertension	2.1e-05	0.000111	CcSEcCtD
Avanafil—CYP3A4—Metapathway biotransformation—CYP19A1—hypertension	2.09e-05	0.000337	CbGpPWpGaD
Avanafil—Rash—Timolol—hypertension	2.08e-05	0.00011	CcSEcCtD
Avanafil—Dermatitis—Timolol—hypertension	2.08e-05	0.00011	CcSEcCtD
Avanafil—Headache—Timolol—hypertension	2.07e-05	0.000109	CcSEcCtD
Avanafil—Dizziness—Lisinopril—hypertension	2.03e-05	0.000107	CcSEcCtD
Avanafil—Nausea—Ramipril—hypertension	2.01e-05	0.000106	CcSEcCtD
Avanafil—CYP3A4—Biological oxidations—COMT—hypertension	1.97e-05	0.000318	CbGpPWpGaD
Avanafil—Nausea—Timolol—hypertension	1.96e-05	0.000104	CcSEcCtD
Avanafil—Vomiting—Lisinopril—hypertension	1.95e-05	0.000103	CcSEcCtD
Avanafil—CYP3A4—Metapathway biotransformation—COMT—hypertension	1.94e-05	0.000314	CbGpPWpGaD
Avanafil—Rash—Lisinopril—hypertension	1.93e-05	0.000102	CcSEcCtD
Avanafil—Dermatitis—Lisinopril—hypertension	1.93e-05	0.000102	CcSEcCtD
Avanafil—Headache—Lisinopril—hypertension	1.92e-05	0.000102	CcSEcCtD
Avanafil—Nausea—Lisinopril—hypertension	1.82e-05	9.63e-05	CcSEcCtD
Avanafil—CYP3A4—Biological oxidations—GSTM1—hypertension	1.8e-05	0.000291	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—GSTM1—hypertension	1.78e-05	0.000287	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—CYP1A1—hypertension	1.71e-05	0.000276	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—FAH—hypertension	1.69e-05	0.000272	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—CYP1A1—hypertension	1.68e-05	0.000272	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HYAL2—hypertension	1.28e-05	0.000206	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HAS1—hypertension	1.28e-05	0.000206	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HAS3—hypertension	1.28e-05	0.000206	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PNMT—hypertension	1.28e-05	0.000206	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HAS2—hypertension	1.28e-05	0.000206	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—QDPR—hypertension	1.28e-05	0.000206	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—POMC—hypertension	1.27e-05	0.000206	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GSTA5—hypertension	1.2e-05	0.000194	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CPS1—hypertension	1.14e-05	0.000184	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CDO1—hypertension	1.14e-05	0.000184	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—MDH1—hypertension	1.14e-05	0.000184	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GSTT2—hypertension	1.14e-05	0.000184	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HYAL1—hypertension	1.14e-05	0.000184	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP4F12—hypertension	1.09e-05	0.000175	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GCH1—hypertension	1.09e-05	0.000175	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PLCD1—hypertension	1.04e-05	0.000168	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP11B1—hypertension	1e-05	0.000162	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—AHCY—hypertension	1e-05	0.000162	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GSTM5—hypertension	9.68e-06	0.000156	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—DBH—hypertension	9.68e-06	0.000156	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALOX12—hypertension	9.68e-06	0.000156	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—EPHX2—hypertension	9.68e-06	0.000156	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GBA—hypertension	9.68e-06	0.000156	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP2J2—hypertension	9.37e-06	0.000151	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ARG1—hypertension	9.1e-06	0.000147	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—COX5B—hypertension	9.1e-06	0.000147	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—DECR1—hypertension	9.1e-06	0.000147	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GLS2—hypertension	9.1e-06	0.000147	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALAD—hypertension	8.63e-06	0.000139	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—STS—hypertension	8.23e-06	0.000133	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PLCE1—hypertension	8.23e-06	0.000133	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALDH7A1—hypertension	8.23e-06	0.000133	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ARG2—hypertension	7.89e-06	0.000127	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP4A11—hypertension	7.89e-06	0.000127	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CBS—hypertension	7.89e-06	0.000127	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—XDH—hypertension	7.74e-06	0.000125	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP3A5—hypertension	7.59e-06	0.000123	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SLC5A2—hypertension	7.59e-06	0.000123	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PTGIS—hypertension	7.59e-06	0.000123	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—UCP2—hypertension	7.33e-06	0.000118	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—UCP3—hypertension	7.33e-06	0.000118	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ABCC1—hypertension	7.33e-06	0.000118	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HSD11B1—hypertension	7.33e-06	0.000118	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—TPH1—hypertension	7.33e-06	0.000118	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALAS1—hypertension	7.1e-06	0.000115	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SLC2A3—hypertension	7.1e-06	0.000115	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP11B2—hypertension	7.1e-06	0.000115	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HSD3B1—hypertension	7e-06	0.000113	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ADA—hypertension	7e-06	0.000113	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—FADS1—hypertension	6.9e-06	0.000111	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—AQP1—hypertension	6.9e-06	0.000111	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CA9—hypertension	6.71e-06	0.000108	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—TBXAS1—hypertension	6.71e-06	0.000108	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALOX5AP—hypertension	6.54e-06	0.000106	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALOX15—hypertension	6.54e-06	0.000106	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HADHA—hypertension	6.38e-06	0.000103	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—LHB—hypertension	6.38e-06	0.000103	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—KCNJ11—hypertension	6.24e-06	0.000101	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—LPA—hypertension	6.24e-06	0.000101	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HSD3B2—hypertension	6.24e-06	0.000101	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP2C18—hypertension	5.98e-06	9.66e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—LRP2—hypertension	5.98e-06	9.66e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HSPG2—hypertension	5.76e-06	9.3e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GLP1R—hypertension	5.56e-06	8.98e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALOX5—hypertension	5.56e-06	8.98e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALDH2—hypertension	5.08e-06	8.21e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HBA1—hypertension	4.95e-06	8e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP11A1—hypertension	4.92e-06	7.95e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SLC9A1—hypertension	4.84e-06	7.81e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GSTT1—hypertension	4.84e-06	7.81e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CETP—hypertension	4.78e-06	7.72e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GCLC—hypertension	4.78e-06	7.72e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP17A1—hypertension	4.58e-06	7.39e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ENO1—hypertension	4.53e-06	7.32e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PTGS1—hypertension	4.53e-06	7.32e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CTGF—hypertension	4.36e-06	7.04e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HMGCR—hypertension	4.32e-06	6.98e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GOT2—hypertension	4.32e-06	6.98e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ADRA2A—hypertension	4.23e-06	6.83e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—TH—hypertension	3.96e-06	6.4e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CALM2—hypertension	3.95e-06	6.37e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SLC2A4—hypertension	3.85e-06	6.22e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GCG—hypertension	3.85e-06	6.22e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GOT1—hypertension	3.73e-06	6.03e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP19A1—hypertension	3.62e-06	5.85e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—STK11—hypertension	3.62e-06	5.85e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—COMT—hypertension	3.37e-06	5.44e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GNB3—hypertension	3.32e-06	5.36e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PPARGC1A—hypertension	3.32e-06	5.36e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HMOX1—hypertension	3.31e-06	5.34e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CAT—hypertension	3.26e-06	5.27e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GNAS—hypertension	3.23e-06	5.22e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—APOB—hypertension	3.17e-06	5.11e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GSTM1—hypertension	3.08e-06	4.97e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—LPL—hypertension	3.02e-06	4.88e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ADCY5—hypertension	2.96e-06	4.78e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GPX1—hypertension	2.95e-06	4.76e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PRKCA—hypertension	2.92e-06	4.72e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP1A1—hypertension	2.92e-06	4.72e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CD36—hypertension	2.87e-06	4.64e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—MTHFR—hypertension	2.72e-06	4.4e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PPARA—hypertension	2.67e-06	4.31e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—AGT—hypertension	2.59e-06	4.18e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CALM1—hypertension	2.54e-06	4.11e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—APOE—hypertension	2.53e-06	4.09e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CAV1—hypertension	2.51e-06	4.06e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—APOA1—hypertension	2.51e-06	4.05e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PPARG—hypertension	2.21e-06	3.57e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—POMC—hypertension	2.18e-06	3.52e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—INS—hypertension	2.17e-06	3.5e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALB—hypertension	1.98e-06	3.21e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PIK3R1—hypertension	1.9e-06	3.07e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—NOS3—hypertension	1.9e-06	3.07e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PTGS2—hypertension	1.74e-06	2.8e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PTEN—hypertension	1.51e-06	2.45e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—EP300—hypertension	1.44e-06	2.33e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—AKT1—hypertension	8.73e-07	1.41e-05	CbGpPWpGaD
